These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21512274)

  • 21. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
    Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
    Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
    J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan.
    Choi B; Chun E; Kim M; Kim ST; Yoon K; Lee KY; Kim SJ
    J Clin Immunol; 2011 Apr; 31(2):253-64. PubMed ID: 20981478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Background data on NOD/Shi-scid IL-2Rγ
    Kasahara K; Fukunaga Y; Igura S; Andoh R; Saito T; Suzuki I; Kanemitsu H; Suzuki D; Goto K; Nakamura D; Mochizuki M; Yasuda M; Inoue R; Tamura K; Nagatani M
    J Toxicol Sci; 2017; 42(6):689-705. PubMed ID: 29142168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies.
    Schueler J; Wider D; Klingner K; Siegers GM; May AM; Wäsch R; Fiebig HH; Engelhardt M
    PLoS One; 2013; 8(11):e79939. PubMed ID: 24223204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
    Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
    Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse.
    Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
    Exp Anim; 2014; 63(3):289-96. PubMed ID: 25077758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
    Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
    PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
    Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
    J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
    Ito M; Kobayashi K; Nakahata T
    Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
    Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
    Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of liposome-encapsulated hemoglobin on human immune system: evaluation in immunodeficient mice reconstituted with human cord blood stem cells.
    Kawaguchi AT; Kametani Y; Kato S; Furuya H; Tamaoki K; Habu S
    Artif Organs; 2009 Feb; 33(2):169-76. PubMed ID: 19178463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
    Christianson SW; Greiner DL; Hesselton RA; Leif JH; Wagar EJ; Schweitzer IB; Rajan TV; Gott B; Roopenian DC; Shultz LD
    J Immunol; 1997 Apr; 158(8):3578-86. PubMed ID: 9103418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.
    Takahashi M; Tsujimura N; Yoshino T; Hosokawa M; Otsuka K; Matsunaga T; Nakasono S
    PLoS One; 2012; 7(12):e50448. PubMed ID: 23226520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
    Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
    Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
    Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
    Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) mice.
    Ishikawa Y; Usui T; Shiomi A; Shimizu M; Murakami K; Mimori T
    Eur J Immunol; 2014 Nov; 44(11):3453-63. PubMed ID: 25154613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
    Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
    Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.